Table 1.
Author | Year | Country | Number of patients | Estimated lifetime risk in general population (%) |
Male MS patients |
Female MS patients |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Age-adjusted risk for children | Relative risk for children | Age-adjusted risk for children | Relative risk for children | |||||||||
Nielsen et al. [20] |
2005 |
Denmark |
8205 |
Men, 0.3; women, 0.5 |
- |
Daughter |
7.5 |
- |
Daughter |
4.5 |
||
Son |
7.5 |
Son |
9.5 |
|||||||||
|
|
|
|
|
|
|
Total |
7.5 |
|
|
Total |
6.3 |
Prokopenko et al. [23] |
2003 |
Italy (Sardinia) |
313 |
0.157 |
- |
- |
Total |
3.19 |
Total |
20.3 |
||
Carton et al. [22] |
1997 |
Belgium |
674 |
0.175 |
Total |
1.51 |
Total |
8.6 |
Total |
1.87 |
Total |
10.7 |
Robertson et al. [21] |
1996 |
UK |
674 |
0.3 (men, 0.13; women, 0.66) |
Daughter |
7.12 |
Daughter |
10.8 |
Daughter |
1.74 |
Daughter |
2.6 |
Son |
2.54 |
Son |
19.5 |
Son |
0.0 |
Son |
0.0 |
|||||
|
|
|
|
|
Total |
4.91 |
Total |
16.4 |
Total |
0.81 |
Total |
2.7 |
Sadovnick and Baird [24] |
1988 |
Canada |
815 |
0.1 |
Daughter |
5.13 |
Daughter |
51.3 |
Daughter |
4.96 |
Daughter |
49.6 |
Son |
0.0 |
Son |
0.0 |
Son |
0.0 |
Son |
0.0 |
|||||
Total | 2.47 | Total | 24.7 | Total | 2.58 | Total | 25.8 |